Merck KGaA has tapped TBWA on three of its consumer healthcare brands: Nasivin, Femibion and Flexagil.
TBWA will handle global communication strategies for each of the brands. The campaigns will debut globally in 2009, according to a company statement.
Neither company responded to inquiries about the assignment. In the statement, Hubertus von Lobenstein, CEO TBWAGroup Germany, said of the wins: “It shows the value of a great team, the international experience as well as the power of our fundamental idea: Disruption.”
Merck’s global operating activities function under the umbrella Merck KGaA of Germany, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%, according to the statement. Merck & Co., the US subsidiary, became an independent company in 1917.
